It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

China plans to accelerate the establishment of a tiered healthcare delivery system, focusing on strengthening primary-level medical capacity to manage common and chronic diseases such as hypertension and diabetes, authorities said.

Hologic has launched its Novodiag system in Europe. The Waltham, MA-based company inherited the automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance when it acquired Mobidiag Oy for $795 million.

Quidel announced Thursday that preliminary estimates for its third quarter revenues are expected to rise between 6 and 7 percent year over year on COVID-19 assay sales.

PerkinElmer said on Thursday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's assay to detect SARS-CoV-2 and the flu.

On Sep. 29, 2021, ET Healthcare announced that it was granted the ST2 patent of Critical Care Diagnostics, Inc. (CCD). So far, 7 Chinese companies have been legally authorized to manufacture and / or sell ST2 reagent products

FDA brought medtech up to speed on several key medical device programs during the CDRH Townhall at The MedTech Conference.

Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a combined home collection kit for molecular testing for COVID-19 and influenza A/B.

Point-of-care testing firm EKF Diagnostics said on Wednesday that it has agreed to acquire Advanced Diagnostics Laboratory (ADL Health) for $10 million in shares and additional performance-based payments of up to $60 million over the next three years.

Genedrive announced on Wednesday that it has received CE marking for the next generation of its Genedrive System gene amplification platform.

On September 28, 2021, the " Fifteenth China Listed Company Value Evaluation " list sponsored by Securities Times and co-organized by Caitong Securities was announced. There are a number of in vitro diagnosis companies were listed.

Scienion said on Tuesday that it has entered into a strategic collaboration with diagnostic biotechnology company Pictor to commercialize a high throughput SARS-CoV-2 antibody testing system.